<DOC>
	<DOCNO>NCT02426034</DOCNO>
	<brief_summary>The purpose single arm study assess safety efficacy ATAN ( Apatinib ) patient Chemo-refractory Advanced Metastatic Adenocarcinoma Stomach Gastroesophageal Junction clinical practice . ATAN give patient fail least two line prior chemotherapy . Eligible patient receive ATAN treatment ( 850 mg qd p.o . ) continually disease progression intolerable toxicity patient withdrawal consent , target sample size 2000+ individual .</brief_summary>
	<brief_title>Study Apatinib Tablets Treatment Advanced Metastatic Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . Age : 18 to75 year old ; 2 . Pathologically diagnose advanced gastric cancer ( include adenocarcinoma gastroesophageal junction ) measurable metastasis outside stomach ( measure ≥ 10mm spiral CT scan , satisfy criterion RECIST 1.1 ) ; 3 . Failure prior therapy ( treatment ) patient receive least two prior chemotherapy regimen ; 4 . ECOG PS 02 ; 5 . Major organ function meet follow criterion : For result blood routine test ( without blood transfusion within 14 day ) : HB ≥ 90g / L ANC ≥ 1.5 × 109 / L PLT ≥ 80 × 109 / L Biochemical test result : Bilirubin &lt; 1.25 time upper limit normal ( ULN ) ALT AST &lt; 2.5 × ULN ; liver metastasis , , ALT AST &lt; 5 × ULN Serum Cr ≤ 1 × ULN endogenous creatinine clearance &gt; 50ml/min ( CockcroftGault formula ) 6 . An expected survival ≥ 3 month ; 7 . Patient receive apatinib treatment regimen investigator ' discretion ; 8 . Patient voluntarily join study sign Informed Consent Form study ; 9 . Pregnancy test ( serum urine ) perform woman childbearing age within 7 day enrolment test result must negative . They shall take appropriate method contraception study 8th week post last administration study drug . For men , ( previous surgical sterilization accept ) , shall agree take appropriate method contraception study 8th week post last administration study drug . 1 . Subjects poorcontrolled arterial hypertension ( systolic blood pressure &gt; 140 mmHg diastolic blood pressure &gt; 90 mm Hg ) despite standard medical management ; Coronary heart disease great ClassII ; IIlevel arrhythmia ( include QT interval prolongation , man ≥ 450 m , woman ≥ 470 m ) together Class II cardiac dysfunction ; 2 . Factors could effect oral medication ( inability swallow , chronic diarrhea intestinal obstruction ) ; 3 . Subjects high gastrointestinal bleeding risk , include follow condition : local active ulcer lesion positive fecal occult blood test ( ++ ) ; history black stool , vomit blood past 3 month ; unresected primary lesion stomach positive fecal occult blood test ( + ) , ulcerated gastric carcinoma massive alimentary tract bleed risk judge PIs base gastric endoscopy result ; 4 . Abnormal Coagulation ( INR &gt; 1.5、APTT &gt; 1.5 UNL ) , tendency bleed ; 5 . Associated CNS ( central nervous system ) metastases ; 6 . Pregnant lactating woman ; 7 . Other condition regiment investigator ' discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Advanced</keyword>
	<keyword>Metastatic</keyword>
</DOC>